Transactions

Sell Side Advisor

Kroll's Investment Banking Team Advised AQREVA and Doctors' Resource Specialists on Its Sale to UnisLink

Kroll's Investment Banking Team Advised AQREVA and Doctors' Resource Specialists on Its Sale to UnisLink
/en/our-team

Connect With Us

On August 10, 2023, AQREVA and Doctors' Resource Specialists (DRS) were acquired by UnisLink, a global leader in revenue cycle and population health management systems

It was a pleasure working with the Kroll team as they helped us navigate and manage every step of the transaction. They made sure we approached the right potential buyers and tailored an efficient process which resulted in a successful outcome. Their attention to detail and in-depth understanding of the market were vital in getting this deal done.
– Paula Tollerud President of AQREVA
It was a pleasure working with the Kroll team as they helped us navigate and manage every step of the transaction. They made sure we approached the right potential buyers and tailored an efficient process which resulted in a successful outcome. Their attention to detail and in-depth understanding of the market were vital in getting this deal done.
– Paula Tollerud President of AQREVA

Kroll's Investment Banking team served as exclusive financial advisor to both AQREVA and DRS in connection with the sale of the companies.

About AQREVA

AQREVA is a professional services company offering comprehensive medical billing and revenue cycle related services with offices in Arizona, North Dakota, South Dakota, Oklahoma and Montana. The AQREVA team serves a vast array of clients throughout the United States with a wide range of services for clients, including: clinic start-up, practice management, medical billing and revenue cycle management, coding and compliance reviews, payer contracting and credentialing as well as accounting and payroll services.

About Doctors' Resource Specialists

Doctors’ Resource Specialists (DRS) is an Arizona-based medical billing, medical coding and reimbursement consulting company dedicated to providing the latest information and best services possible to maximize cash flow while allowing healthcare providers more time to spend with patients. The DRS team consists of experienced professionals in medical billing, reimbursement and accounts receivable management as well as credentialing and practice management.

Baker & Hostetler LLP served as legal counsel to AQREVA and DRS in connection with the transaction.

About UnisLink

UnisLink leverages its proprietary software solutions to provide end-to-end revenue cycle management and population health management services to independent physician groups, ACOs and value-based care groups across the United States. Headquartered in Phoenix, AZ, the Company deploys unique technology, analytics and skilled teams to enhance clinical outcomes while improving the financial performance of its customers.

About Riverside Partners

Founded in 1989, Riverside Partners is a middle market private equity firm with total capital commitments of $1.6 billion raised since inception. The firm focuses on growth-oriented companies in the technology and healthcare industries. Riverside Partners is particularly experienced at partnering with founders, owners and management teams, and it brings substantial domain expertise and operating experience to its portfolio companies.

Snell & Wilmer LLP served as legal counsel to UnisLink and Riverside Partners in connection with the transaction.

Stay Ahead with Kroll

Healthcare Investment Banking

Healthcare Investment Banking

Healthcare expertise for middle-market M&A transactions.

Mergers and Acquisitions (M&A) Advisory

Mergers and Acquisitions (M&A) Advisory

Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.

Corporate Finance and Restructuring

Corporate Finance and Restructuring

M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.

Return to top